GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Jibeier Pharmaceutical Co Ltd (SHSE:688566) » Definitions » Total Assets

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Total Assets : ¥2,213.1 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Jibeier Pharmaceutical Co Total Assets?

Jiangsu Jibeier Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥2,213.1 Mil.

Warning Sign:

If a company builds assets at 33.3% a year, faster than its revenue growth rate of 2.6% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Jiangsu Jibeier Pharmaceutical Co's average Total Assets Growth Rate was 36.50% per year. During the past 3 years, the average Total Assets Growth Rate was 47.60% per year. During the past 5 years, the average Total Assets Growth Rate was 33.30% per year.

During the past 8 years, Jiangsu Jibeier Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 47.60%. The lowest was 4.90%. And the median was 18.90%.

Total Assets is connected with ROA %. Jiangsu Jibeier Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 9.50%. Total Assets is also linked to Revenue through Asset Turnover. Jiangsu Jibeier Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.09.


Jiangsu Jibeier Pharmaceutical Co Total Assets Historical Data

The historical data trend for Jiangsu Jibeier Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Jibeier Pharmaceutical Co Total Assets Chart

Jiangsu Jibeier Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 595.62 1,747.26 1,818.69 1,964.58 2,209.67

Jiangsu Jibeier Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,964.51 2,045.25 2,118.92 2,209.67 2,213.11

Jiangsu Jibeier Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Jiangsu Jibeier Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1910.419+299.249
=2,209.7

Jiangsu Jibeier Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=1965.451+247.66
=2,213.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Jibeier Pharmaceutical Co  (SHSE:688566) Total Assets Explanation

Total Assets is connected with ROA %.

Jiangsu Jibeier Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=210.052/( (2209.668+2213.112)/ 2 )
=210.052/2211.39
=9.50 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Jiangsu Jibeier Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=194.231/( (2209.668+2213.112)/ 2 )
=194.231/2211.39
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Jiangsu Jibeier Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Jiangsu Jibeier Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Business Description

Traded in Other Exchanges
N/A
Address
High-tech Industrial Development Zone, Jiangsu Province, Zhenjiang, CHN, 212000
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
Executives
Wu Ying senior management
Zhang Chun Director
Zhao Suo Fu senior management
Li Hai Dao Core technical personnel
Di Jian Zhong senior management
Qin Xu Feng Core technical personnel
Wu Xiu Gen Core technical personnel
Yu Xin Jun Directors, senior managers
Hu Tao Director

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Headlines

No Headlines